Sign in
Legislation Comparison Grid and Testimony/Advocacy Statement
Number of sources: 3
Paper instructions:
To Prepare:
Select a bill that has been proposed (not one that has been enacted) using the congressional websites provided in the Learning Resources.
The Assignment: (1- to 2-page Comparison Grid; 1- to 2-page Legislation Testimony/Advocacy Statement)
Part 1: Legislation Comparison Grid
Based on the health-related bill (proposed, not enacted) you selected, complete the Legislation Comparison Grid Template. Be sure to address the following:
Determine the legislative intent of the bill you have reviewed.
Identify the proponents/opponents of the bill.
Identify the target populations addressed by the bill.
Where in the process is the bill currently? Is it in hearings or committees?
Is it receiving press coverage?
Part 2: Legislation Testimony/Advocacy Statement
Based on the health-related bill you selected, develop a 1- to 2-page Legislation Testimony/Advocacy Statement that addresses the following:
Advocate a position for the bill you selected and write testimony in support of your position.
Describe how you would address the opponent to your position. Be specific and provide examples.
Recommend at least one amendment to the bill in support of your position.
Legislation Comparison Grid Template
Use this document to complete Part 1 of the Module 2 Assessment Legislation Comparison Grid and Testimony/Advocacy Statement
Health-related Bill Name
Bill Number
Description
Federal or State?
Legislative Intent
Proponents/ Opponents Proponents:
Opponents:
Target Population
Status of the bill (Is it in hearings or committees? Is it receiving press coverage?)
General Notes/Comments
___________________________
Health-related Bill Name: Affordable Insulin Act of 2023
Bill Number: H.R. 6833
Description: This bill would cap the cost of insulin at $35 per month for insured and uninsured Americans.
Federal or State?: Federal
Legislative Intent: To make insulin more affordable for Americans.
Proponents/Opponents:
Proponents:
- Patients with diabetes
- Healthcare providers
- Diabetes organizations
- Consumer groups
- Some members of Congress
Opponents:
- Pharmaceutical companies
- Some members of Congress
Target Population: Americans with diabetes
Status of the bill (Is it in hearings or committees? Is it receiving press coverage?)
The bill is currently in the House Energy and Commerce Committee. It has received significant press coverage, with stories appearing in major news outlets such as The New York Times, The Washington Post, and CNN.
General Notes/Comments:
The Affordable Insulin Act of 2023 is a bipartisan bill that has the potential to make a major impact on the lives of Americans with diabetes. The bill has strong support from patients, healthcare providers, and diabetes organizations. However, it faces opposition from pharmaceutical companies, which have a vested interest in keeping insulin prices high. The bill is currently in the House Energy and Commerce Committee, and it is unclear whether it will pass the House or the Senate. If it does pass, it would be a major victory for patients with diabetes and a significant step towards making insulin more affordable.
